PTC Inc. PTC is scheduled to report first-quarter fiscal 2026 results on Feb. 4, after market close. For the quarter, PTC anticipates revenues between $600 million and $660 million. Non-GAAP EPS is ...

Earnings call PTC delivered Q1 FY26 ARR growth of 9% YoY (ex-Kepware/ThingWorx) and 13% YoY free cash flow growth, with revenue and EPS exceeding guidance. Management ...

In a potentially pivotal trial, PTC Therapeutics' experimental therapy for Huntington's disease (HD) met its primary endpoint, but questions about the data have raised doubts about the company's ...

More than two years after its approval in Europe, PTC Therapeutics' gene therapy for rare genetic disorder AADC deficiency will soon be made available to patients in the US. The FDA has approved PTC's ...

PTC India Limited (PTC) is a provider of power trading solutions in India. The Company is engaged in investing in equity or extending debt to power projects in generation, transmission, distribution, ...

PTC Industries Limited is an India-based company, which is engaged in manufacturing of precision metal components for critical applications. It is primarily engaged in the manufacturing of metal ...

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Choi Min-Jeong, Kim Gil-Li, Shim Suk-Hee, and No Do-Hee powered South Korea to gold in the women's 3000m relay, claiming the country's seventh title in the event's 10 Olympic contests. South Korea, ...

Time to act on PTC? Chart does not reflect overnight price.